DCM
NUVB icon

DME Capital Management’s Nuvation Bio NUVB Stock Holding History

DME Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Hold
34,995
– – 0.01% 46
2026
Q1 		$150K Hold
34,995
– – ﹤0.01% 44
2025
Q4 		$314K Hold
34,995
– – 0.01% 39
2025
Q3 		$129K Hold
34,995
– – 0.01% 35
2025
Q2 		$68.2K Hold
34,995
– – ﹤0.01% 32
2025
Q1 		$61.6K Hold
34,995
– – ﹤0.01% 31
2024
Q4 		$93.1K Hold
34,995
– – ﹤0.01% 34
2024
Q3 		$80.1K Hold
34,995
– – ﹤0.01% 36
2024
Q2 		$102K Hold
34,995
– – 0.01% 37
2024
Q1 		$127K Buy
+34,995
New +$67.2K 0.01% 39

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DME Capital Management's NUVB Position: Q2 2026 in Review

DME Capital Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 34,995 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #46.

DME Capital Management first reported a position in NUVB in Q1 2024 and has held it in 10 quarters since. The position peaked at $314K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • DME Capital Management held 34,995 shares of Nuvation Bio worth $199K as of Q2 2026.
  • DME Capital Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.01% of DME Capital Management's portfolio in Q2 2026, its #46 holding.
  • DME Capital Management first reported a position in Nuvation Bio in Q1 2024 and has held it in 10 quarters since.
  • DME Capital Management's Nuvation Bio position peaked at $314K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.